GlyCAM-1, a physiologic ligand for L-selectin, activates β2 integrins on naive peripheral lymphocytes

Sam T. Hwang, Mark S. Singer, Patricia A. Giblin, Ted A. Yednock, Kevin B. Bacon, Scott I Simon, Steven D. Rosen

Research output: Contribution to journalArticlepeer-review

158 Scopus citations


Naive T cells are selectively recruited from the blood into peripheral lymph nodes during lymphocyte recirculation. L-selectin, a lectin-like receptor, mediates the initial attachment of lymphocytes to high endothelial venules (HEV) in lymph nodes. A subsequent step involving the activation of β2 integrins has been proposed to facilitate firm adhesion, but the activating signals are poorly understood. We report here that here that either antibody-mediated cross-linking of L-selectin on human lymphocytes or treatment of the cells with GlyCAM-1, an HEV-derived, secreted ligand for L- selectin, stimulates their binding to ICAM-1 through the β2 integrin pathway. Furthermore, GlyCAm-1 causes the rapid expression of a neoepitope on β2 integrins associated with a high-avidity state. Naive (CD45RA+), but not memory (CD45RO+) lymphocytes, respond to L-selectin cross-linking or GlyCAM- 1 treatment. Thus, the complexing of L-selectin by specific ligands may provide key signals to naive lymphocytes, contributing to their selective recruitment into peripheral lymphoid organs.

Original languageEnglish (US)
Pages (from-to)1343-1348
Number of pages6
JournalJournal of Experimental Medicine
Issue number4
StatePublished - Oct 1 1996
Externally publishedYes

ASJC Scopus subject areas

  • Immunology


Dive into the research topics of 'GlyCAM-1, a physiologic ligand for L-selectin, activates β2 integrins on naive peripheral lymphocytes'. Together they form a unique fingerprint.

Cite this